Free Republic

Novavax Inc. saw its share price skyrocket, more than 25% at one point, since it released positive late-stage data for its experimental Covid-19 vaccine — results analysts have pointed to as promising for the company's future.Shares have continued to rise since the Gaithersburg vaccine maker announced after the closing bell last Thursday that its coronavirus vaccine candidate was 96.4% effective against the original version of the virus, provided complete protection against severe cases and showed some efficacy against emerging variants, according to data from a late-stage clinical trial in the United Kingdom. The findings follow interim data that similarly drove...

A variant of the coronavirus that emerged in the U.K. and has now been identified in over 80 countries could become the dominant form of the virus worldwide, according to the head of the U.K.’s genetic surveillance program.

The AstraZeneca vaccine has been found to be mostly effective against the United Kingdom variant of the CCP virus, according to preliminary data published on Feb. 4.The B.1.1.7 variant has been responsible for most CCP virus cases in the United Kingdom after it first emerged in the country last November. The variant has also been detected in the United States.“Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus but also protects against the novel variant, B.1.1.7, which caused the surge in disease from the end...

From a chaotic vaccine roll-out to the fast-spreading variant, here's the latest news about the novel coronavirus in Florida. Nine things to know, as of Jan. 11: 1. Florida reported almost 20,000 COVID-19 cases Jan. 8 and more than 15,000 cases Jan. 9, reports The New York Times. 2. At least 22 cases of the fast-spreading U.K. coronavirus variant have been confirmed in Florida, the CDC said Jan. 8. The agency has reported 60 total cases in the U.S. across eight states. 3. Florida is allowing everyone 65 and older access to the COVID-19 vaccine, a move that has led...